Clinical Trial

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 13, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-02-12; most recent amendment 2025-05-09.
Status change: Not Yet Recruiting → Recruiting 2021-10-04
Trial Details
NCT Number NCT04755764
Lead Sponsor Marshall University
Conditions Systolic Hypertension, Pregnancy Related, Diastolic Hypertension, Cardiac Output, Low, Cardiac Output, High
Enrollment 60 participants
Start Date 2021-03-03
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-13